GlassScriptPhysician profile
Vincent C Herlevic
NPI 1194111518
$5,838.93
in general payments reported to CMS, 2019-2025
33 companies · $653 in 2025
The $653 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $131 · 2021: $894 · 2022: $1,439 · 2023: $998 · 2024: $1,261 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,902 · Education: $10.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,902.38 |
| Education | $10.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,846.91 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $879.10 | 2022-2024 | Trulance, Xifaxan, Plenvu |
| Janssen Biotech, INC. | $593.00 | 2021-2025 | Tremfya, Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $498.86 | 2019-2025 | Entyvio |
| Celgene Corporation | $430.11 | 2021-2024 | Zeposia |
| Phathom Pharmaceuticals, INC. | $236.98 | 2023-2025 | Voquezna |
| Ardelyx, INC. | $138.37 | 2023-2025 | Ibsrela |
| Mauna Kea Technologies, INC. | $102.30 | 2024-2025 | |
| Intercept Pharmaceuticals, INC. | $100.72 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $98.51 | 2019-2024 | Dificid |
| Regeneron Healthcare Solutions, INC. | $83.81 | 2024-2025 | Dupixent |
| Nestle Healthcare Nutrition INC. | $82.39 | 2021-2022 | |
| Gilead Sciences, INC. | $77.79 | 2020-2023 | |
| Qol Medical, LLC | $77.77 | 2025 | Sucraid |
| Boston Scientific Corporation | $72.52 | 2022-2024 | Compliance Endokit, Captivator II |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $64.18 | 2022-2024 | |
| Olympus America INC. | $57.52 | 2022 | |
| Medtronic, INC. | $45.04 | 2022 | |
| Genzyme Corporation | $44.89 | 2022-2024 | |
| Evoke Pharma, INC. | $38.52 | 2022-2024 | |
| Tersera Therapeutics LLC | $36.09 | 2025 | Xermelo |
| Janssen Pharmaceuticals, INC | $31.90 | 2022-2025 | |
| Cook Medical LLC | $30.97 | 2023 | Evolution |
| Aimmune Therapeutics, INC. | $30.52 | 2024 | |
| Amgen INC. | $25.92 | 2021 | |
| Stryker Corporation | $19.41 | 2023 | Neptune |
| Ipsen Biopharmaceuticals, INC | $15.42 | 2025 | Iqirvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.46 | 2023 | Cyltezo |
| Braintree Laboratories, INC. | $14.32 | 2020 | |
| Celltrion USA INC. | $13.71 | 2024 | Vegzelma |
| Redhill Biopharma INC. | $12.96 | 2023 | |
| Covidien LP | $12.22 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Herlevic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.